Sustained Effectiveness or Inevitable Discontinuation? Five-Year Real-World Outcomes of Teriflunomide Therapy in Multiple Sclerosis

Ozakbas, SerkanAlizada, SaidSamadzade, UlviCaliskan, Can2025-12-302025-12-3020251352-45851477-0970https://hdl.handle.net/20.500.14365/8523eninfo:eu-repo/semantics/closedAccessSustained Effectiveness or Inevitable Discontinuation? Five-Year Real-World Outcomes of Teriflunomide Therapy in Multiple SclerosisConference Object